| Literature DB >> 16854087 |
Yun-Fei Li1, Gui-Feng Wang, Pei-Lan He, Wei-Gang Huang, Feng-Hua Zhu, He-Yong Gao, Wei Tang, Yu Luo, Chun-Lan Feng, Li-Ping Shi, Yu-Dan Ren, Wei Lu, Jian-Ping Zuo.
Abstract
A series of novel benzimidazole derivatives was synthesized and evaluated for their anti-hepatitis B virus (HBV) activity and cytotoxicity in vitro. Strong activity against HBV replication and low cytotoxicity were generally observed in these benzimidazoles. The most promising compounds were 12a and 12b, with similar high antiviral potency (IC50 = 0.9 and 0.7 microM, respectively) and remarkable selectivity indices (>1111 and 714, respectively). They were selected for further evaluation as novel HBV inhibitors.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16854087 DOI: 10.1021/jm060330f
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446